Literature DB >> 12140713

Botulinum toxin urethral sphincter injection resolves urinary retention after pubovaginal sling operation.

C P Smith1, M O'Leary, J Erickson, G T Somogyi, M B Chancellor.   

Abstract

The management of prolonged urinary retention following pubovaginal sling surgery typically involves transvaginal urethrolysis for anatomical urethral obstruction. Brubaker [1] recently reported on urethral sphincter abnormalities as a cause of postoperative urinary retention following either Burch suspension or pubovaginal sling procedure. We report a case of functional urethral obstruction and detrusor acontractility following pubovaginal sling surgery that was successfully treated by botulinum A toxin urethral sphincter injection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12140713     DOI: 10.1007/s192-002-8350-6

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  2 in total

1.  Urinary retention following tension-free vaginal tape successfully treated by sacral neuromodulation.

Authors:  Rony A Adam
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-01-12

Review 2.  [Botulinum toxin in urology. An inventory].

Authors:  H Schulte-Baukloh; H H Knispel
Journal:  Urologe A       Date:  2004-08       Impact factor: 0.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.